St. Louis, MO. — SentiAR, Inc., A start-up medical device company, today announced it has appointed Jim Zimmerman as its new Vice President of Marketing and Sue Hibbeln as Vice President of Quality and Regulatory.
Mr. Zimmerman brings over 25 years of med-device product commercialization experience. He began his career in medical devices at Medtronic, where over an 18-year period he held roles of successive responsibility in product development, sales and marketing. His most recent role at Medtronic was leading the world-wide marketing efforts for their $2B pacemaker franchise. After Medtronic, Jim worked at Nonin Medical, a small, privately held company that develops pulse oximetry, respiratory and other noninvasive monitoring solutions where he led their product commercialization and strategy development efforts. Over the past 4 years, he has owned a marketing consulting business specializing in assisting small and start-up medical device companies develop their strategic and tactical marketing plans. He obtained his bachelors degree in Electrical Engineering from The University of North Dakota and an MBA from the University of St. Thomas in St. Paul, MN.
Ms. Hibbeln has worked at several small and start-up companies, helping them establish their quality and regulatory systems. At CP Medical she established a quality system and submitted 510(k)s for various absorbable and nonabsorbable synthetic and natural material suture devices. She also worked at Calypso Medical (now Varian) on a “GPS for the body” technology, registering them for use in multiple geographies around the world. Most recently, Sue was Head of Quality and Regulatory for Ambra Health, a start-up that produces picture archiving and telecommunication systems to improve accessibility of information. She obtained a bachelors degree in Political Science from LaSalle University in Philadelphia and a master’s degree in Regulatory Affairs from San Diego State University.
About SentiAR, Inc.
SentiAR, Inc., based in St. Louis, MO., is developing and commercializing a 3D augmented reality visualization solution for intraoperative use by an Electrophysiologist during an ablation/mapping procedure of the heart. The SentiAR system takes real-time electro anatomic mapping system imagery and correlating catheter position data and provides 3D holograph images to the clinician user. Spatial navigation and acuity of images is achieved using gaze and voice commands to self-manipulate the scale, rotation, and positioning of the imagery to the preferred user perspective. The product is currently limited by federal law to investigational use only. SentiAR is planning on submitting the product to the FDA for their review this fall.
